Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead faces challenge to European patent on pricey hep C drug
Yahoo/Reuters
Tue, 02/10/15 - 10:21 am
Tags:
Gilead Sciences, Europe, patents, hepatitis C, Sovaldi
Big Pharma Faces Some Big Patent Losses, but Pipelines are Improving
WSJ Pharmalot
Tue, 02/10/15 - 08:41 am
Tags:
patents, Big Pharma, Abilify, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Crestor, Eli Lilly, Gilead Sciences, GSK, Harvoni, Hospira, Merck, Novo Nordisk, Pfizer, Sovaldi, Tecfidera
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Tags:
Achillion, hepatitis C, ACH-3102, Gilead Sciences, Sovaldi
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade
Barron's
Sat, 02/7/15 - 10:23 am
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C
Gilead's Harvoni Selected as Cigna Preferred Treatment for Hepatitis C Genotype 1
NASDAQ.com
Fri, 02/6/15 - 10:25 am
Tags:
Gilead Sciences, Harvoni, Cigna, hepatitis C
[video]3 Things You Ought to Know About Gilead's Tumble
Motley Fool
Fri, 02/6/15 - 09:06 am
Tags:
Gilead Sciences
Bigger drug discounts put question mark over Gilead's stellar run
Fortune
Wed, 02/4/15 - 10:18 am
Tags:
Gilead Sciences, drug discounts, hepatitis C, Sovaldi, Harvoni
Gilead Profit Soars But HCV Drug Rival Weighs On Outlook
Yahoo/Investors Business Daily
Wed, 02/4/15 - 08:24 am
Tags:
Gilead Sciences, earnings
Gilead Sciences is ‘Very Conservative When It Comes to Guidance!’
Barron's
Mon, 02/2/15 - 05:46 pm
Tags:
Gilead Sciences
Can The Biotech Sector See Stellar Results For 2015 Amid Price Wars?
Bidness Etc.
Mon, 02/2/15 - 09:57 am
Tags:
drug pricing, biotech, Gilead Sciences, AbbVie
3 Things to Watch with Gilead Sciences, Inc. Q4 Results
Motley Fool
Mon, 02/2/15 - 07:50 am
Tags:
Gilead Sciences, earnings
In cystic fibrosis drug launch prep, Vertex learns from Sovaldi mistakes
Bizjournals.com
Sat, 01/31/15 - 09:58 am
Tags:
cystic fibrosis, Vertex Pharmaceuticals, Sovaldi, drug launches, Gilead Sciences, lumacaftor
Gilead Sciences, Inc. Continues To Reign Over The Hepatitis C Market
Bidness Etc.
Fri, 01/30/15 - 08:05 am
Tags:
Gilead Sciences, AbbVie, Harvoni, Sovaldi, hepatitis C, Viekira Pak
Gilead Sciences, Inc. Harvoni Gets Preferred Status From UnitedHealth Group (UNH)
Bidness Etc.
Thu, 01/29/15 - 11:11 am
Tags:
Gilead Sciences, hepatitis C, United Health, Harvoni, AbbVie
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, AbbVie, Viekira Pak
Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment
WSJ Online
Mon, 01/26/15 - 07:52 am
Tags:
generics, Gilead Sciences, hepatitis C, Sovaldi, India
Patients Blame Cost for Coverage Delay in England of Gilead Drug
WSJ Pharmalot
Fri, 01/23/15 - 08:21 am
Tags:
UK, Gilead Sciences, patients, Sovaldi, hepatitis C
Gilead’s John Martin Named Morningstar CEO of 2014
Barron's
Wed, 01/21/15 - 06:00 pm
Tags:
John Martin, Gilead Sciences, Pharma CEOs
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C, drug pricing, Viekira Pak, Harvoni, Sovaldi
Can Gilead Sciences Beat Hep-C Estimates?
Barron's
Tue, 01/20/15 - 03:59 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.